Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

NCT01979484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Assessments in Healthy Volunteers

Interventions

DRUG: PPI-668 capsule
DRUG: PPI-668 tablet

Sponsor

Presidio Pharmaceuticals, Inc.